M

Mayinglong Pharmaceutical Group Co Ltd
SSE:600993

Watchlist Manager
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Watchlist
Price: 26.4 CNY -1.23%
Market Cap: 11.4B CNY
Have any thoughts about
Mayinglong Pharmaceutical Group Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Mayinglong Pharmaceutical Group Co Ltd

Wall Street analysts forecast Mayinglong Pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Mayinglong Pharmaceutical Group Co Ltd is 38.24 CNY with a low forecast of 37.86 CNY and a high forecast of 39.36 CNY.

Lowest
Price Target
37.86 CNY
43% Upside
Average
Price Target
38.24 CNY
45% Upside
Highest
Price Target
39.36 CNY
49% Upside
Mayinglong Pharmaceutical Group Co Ltd Competitors:
Price Targets
600422
KPC Pharmaceuticals Inc
44% Upside
MYX
Mayne Pharma Group Ltd
36% Upside
APLLTD
Alembic Pharmaceuticals Ltd
14% Upside
4568
Daiichi Sankyo Co Ltd
48% Upside
300119
Tianjin Ringpu Bio-Technology Co Ltd
19% Upside
PHO
Photocure ASA
59% Upside
SUNPHARMA
Sun Pharmaceutical Industries Ltd
13% Upside
AZN
AstraZeneca PLC
29% Upside

Revenue
Forecast

Revenue Estimate
Mayinglong Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Mayinglong Pharmaceutical Group Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 13%.

7%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mayinglong Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Mayinglong Pharmaceutical Group Co Ltd's operating income is 9%. The projected CAGR for the next 3 years is 28%.

9%
Past Growth
28%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Mayinglong Pharmaceutical Group Co Ltd

For the last 8 years the compound annual growth rate for Mayinglong Pharmaceutical Group Co Ltd's net income is 9%. The projected CAGR for the next 3 years is 19%.

9%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Mayinglong Pharmaceutical Group Co Ltd's stock price target?
Price Target
38.24 CNY

According to Wall Street analysts, the average 1-year price target for Mayinglong Pharmaceutical Group Co Ltd is 38.24 CNY with a low forecast of 37.86 CNY and a high forecast of 39.36 CNY.

What is Mayinglong Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Mayinglong Pharmaceutical Group Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 13%.

What is Mayinglong Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
28%

For the last 8 years the compound annual growth rate for Mayinglong Pharmaceutical Group Co Ltd's operating income is 9%. The projected CAGR for the next 3 years is 28%.

What is Mayinglong Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Mayinglong Pharmaceutical Group Co Ltd's net income is 9%. The projected CAGR for the next 3 years is 19%.

Back to Top